The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(rac)-7-Isopropyl-5,7,8,9-tetrahydro-6-oxa-4,9-diaza-phenanthren-10-one ID: ALA3736005
PubChem CID: 72699596
Max Phase: Preclinical
Molecular Formula: C14H16N2O2
Molecular Weight: 244.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C1Cc2[nH]c(=O)c3cccnc3c2CO1
Standard InChI: InChI=1S/C14H16N2O2/c1-8(2)12-6-11-10(7-18-12)13-9(14(17)16-11)4-3-5-15-13/h3-5,8,12H,6-7H2,1-2H3,(H,16,17)
Standard InChI Key: BWAOMLAYGRYBIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
0.4558 -2.2973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7503 -1.5498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7896 -2.1497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8205 -1.5498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8205 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1332 0.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4277 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4277 -1.5498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1332 -2.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7184 -2.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7047 -3.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7645 -1.7275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4558 0.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7503 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0631 0.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0631 2.1879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7503 2.9537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4558 2.1879 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13 5 1 0
4 1 1 0
1 2 1 0
2 14 1 0
2 3 2 0
4 5 2 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
10 11 1 0
10 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 244.29Molecular Weight (Monoisotopic): 244.1212AlogP: 2.02#Rotatable Bonds: 1Polar Surface Area: 54.98Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.50CX Basic pKa: 2.80CX LogP: 1.19CX LogD: 1.19Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.83Np Likeness Score: -0.15
References 1. de Vicente J, Tivitmahaisoon P, Berry P, Bolin DR, Carvajal D, He W, Huang KS, Janson C, Liang L, Lukacs C, Petersen A, Qian H, Yi L, Zhuang Y, Hermann JC.. (2015) Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors., 6 (9): [PMID:26396691 ] [10.1021/acsmedchemlett.5b00251 ]